Product information and disease descriptionProduct descriptionProduct informationPharmacology
Mechanism of action
9 evidence topics · 7 sources
Pharmacologic class: APOL1 function inhibitor
Oral small-molecule inhibitor of APOL1 channel function
“The underlying genetic cause of AMKD is a toxic gain-of-function in the APOL1 gene (G1 or G2) thought to enhance APOL1 channel function and damage glomerular cells (e.g., podocytes and endothelial cells) in response to an inflammatory trigger; the resulting cellular damage disrupts the glomerular filtration barrier, resulting in proteinuria, and often leads to accelerated loss of kidney function” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Based on the mechanism of disease, targeted inhibition of APOL1 should inhibit glomerular damage, reduce proteinuria, and ultimately slow the progression of kidney disease.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Inaxaplin (previously known as VX-147) is an oral, small molecule inhibitor of APOL1 channel function that has been shown to reduce proteinuria in patients with AMKD in a phase 2a proof-of-concept study” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Direct binding to APOL1 and inhibition of APOL1-mediated ion flux in cell models
Potency against APOL1 G0, G1, and G2 in channel, trypanolysis, and cell death assays
“we determined VX-147 potently inhibited the APOL1 ion channel with IC50 values of 2.3 nM for G0, 1.3 nM for APOL1 G1, and 1.1 nM for APOL1 G2 (Fig. 3A).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“We found that VX-147 prevented APOL1-mediated T.b.b. death with essentially equivalent potencies to ion channel inhibition, with EC50 values of 2.0 nM for APOL1 G0, 2.1 nM for APOL1 G1, and 1.2 nM for APOL1 G2 (Fig. 3B).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“We saw complete inhibition of APOL1-dependent cell death using VX-147 with EC50 values of 4.3 nM for APOL1 G0, 2.0 nM for APOL1 G1, and 2.2 nM for APOL1 G2 (Fig. 3C).” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Selectivity: off-target profiling
“VX-147 was previously shown to bind directly to purified, recombinant APOL1 and broad profiling across a large panel of potential off-targets did not identify any significant activity, indicating that the mechanism of action is due to direct inhibition of the APOL1 ion channel” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Rationale for limited on-target risk of APOL1 inhibition
“We reasoned an APOL1 ion channel inhibitor would be likely to have limited on-target safety risk, because there is a published report of an individual with no detectable APOL1 protein expression due to homozygous truncation mutations.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“This individual was healthy except for a sensitivity to trypanosome infection” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
Potassium efflux as the proximal driver of APOL1-mediated cell death
Reversal of sodium import, potassium efflux, and downstream injury: independent study
“In HEK293 cells, we demonstrated that G1-mediated Na+ import/K+ efflux triggered activation of GPCR/IP3–mediated calcium release from the ER, impaired mitochondrial ATP production, and impaired translation, which were all reversed by VX-147.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Our study provides the first detailed biochemical mechanism, to our knowledge, that explains how VX-147 protects kidney cells.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote
“Based on these results, we conclude that the cytoprotective effects of VX-147 are not due to a decrease in G1 protein expression or translocation to the PM.” (opens the original PMC page at this quote in a new tab)View highlighted excerpt for this quote